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Abstract
The genetic disease cystic fibrosis is caused by defects in the chloride channel cystic fibrosis transmembrane conductance
regulator (CFTR). CFTR belongs to the family of ABC transporters. In contrast to most other members of this family which
transport substrates actively across a membrane, the main function of CFTR is to regulate passive flux of substrates across
the plasma membrane. Chloride channel activity of CFTR is dependent on protein phosphorylation and presence of
nucleoside triphosphates. From electrophysiological studies of CFTR detailed models of its regulation by phosphorylation
and nucleotide interaction have evolved. These investigations provide ample evidence that ATP hydrolysis is crucial for
CFTR gating. It becomes apparent that the two nucleotide binding domains on CFTR not only diverge strongly in sequence,
but also in function. Based on previous models and taking into account new data from pre-steady-state experiments, a
refined model for the action of nucleotides at two nucleotide binding domains was recently proposed. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The cystic ¢brosis transmembrane conductance
regulator (CFTR) was cloned and sequenced a dec-
ade ago in a collaborative e¡ort of three laboratories
[1^3]. It was the ¢rst gene to be cloned by positional
cloning and, although it could not be known at the
time from the sequence alone, the second chloride
channel cloned (after the glycine receptor [4]). The
initial suggestion that CFTR might be a chloride
channel [3] was met with great reservation [5] because
its primary sequence placed it into a family of active
transporters [3], later called tra⁄c ATPases [6], TM6-
NBF superfamily [7], or, as best known nowadays,
ABC transporters [5].
Overwhelming evidence in the years 1991 and later
proved that CFTR itself functions indeed as a phos-
phorylation- and nucleotide-regulated small-conduc-
tance chloride channel. This function is detailed in
many exhaustive reviews [8^11], most recently in spe-
cial issues, of the Journal of Bioenergetics and Bio-
membranes (e.g. [12]) and of Physiological Reviews
(e.g. [13^15]).
That CFTR is also a regulator of epithelial sodium
channels was shown ¢rst by Stutts et al. [16]. This
channel-regulating function of CFTR was later con-
¢rmed by others who also found CFTR to regulate
many more channels which is again covered in depth
in recent reviews [17,18].
Because CFTR is the topic of another article in
this special issue [19] the following short review will
presuppose knowledge of the structure of CFTR. I
will focus on the nucleotide-mediated gating of
CFTR chloride channels and its modulation by
phosphorylation of CFTR.
2. Phosphorylation activates CFTR chloride channels
The chloride channel activity of CFTR was
studied by di¡erent electrophysiological techniques,
the most important of which are patch clamp studies
in the whole cell-, cell-attached patch-, or excised
patch-mode and single-channel studies after reconsti-
tution in planar black lipid membranes (BLM).
When CFTR was expressed in non-epithelial cells,
activation of cAMP-dependent protein kinase
(PKA) caused the appearance of a chloride conduc-
tance [20,21]. The single-channel conductance of the
underlying channels was found to be about 10 pS
[20], identical to that of endogenously expressed
chloride channels in human epithelial cells [22] ex-
pressing CFTR. The ¢nal proof that CFTR is a
chloride channel was its puri¢cation and reconstitu-
tion in BLM, resulting again in PKA- and ATP-ac-
tivated low-conductance chloride channels [23].
The same channels were also found endogenously
expressed in rat [24] and human [25] pancreatic duct
cells, as well as in heart cells from guinea pig ven-
tricle [26,27] where CFTR expression, albeit weak,
was shown by Northern blotting [27]. Fig. 1 exem-
pli¢es the activation of cardiac CFTR channels by
PKA and ATP. The beginning of the current trace
shows that ATP has no e¡ect on non-phosphorylated
channels, but addition of PKA catalytic subunit to-
gether with ATP leads to a stepwise current increase
which persists upon removal of PKA.
Under physiological conditions, the activation by
PKA is counteracted by protein phosphatases so that
inactivation of PKA is followed by inactivation of
CFTR chloride conductance [24,26]. The fact that
this is di¡erent under the in vitro conditions of an
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excised inside-out membrane patch indicates that
phosphatase activity is relatively low, although it
must be stressed that, depending on the expression
system and the individual membrane patch, residual
protein phosphatase activity is evident (see e.g. ‘run-
down’ in Fig. 2). This protein phosphatase activity
must be membrane-bound as it is also seen under
conditions of vigorous solution exchange (like in
Fig. 2). The participation of protein phosphatases
in CFTR channel activity rundown was shown by
its reversal with renewed application of PKA (e.g.
[28,29]). The fast inactivation upon removal of
ATP, seen in Fig. 1, however, is not related to lack-
ing phosphorylation by PKA (see below).
In accordance with the observed consensus sites
for PKC-phosphorylation on CFTR [3], phosphory-
lation of CFTR by PKC was observed. The e¡ects of
PKC-phosphorylation have been less investigated; it
seems to stimulate the response to PKA [30]. A re-
cent report shows that phosphorylation by basal
PKC-activity is required for activation by PKA
[31]. cGMP-dependent protein kinases (PKG or
Fig. 1. Activation of CFTR by PKA and ATP. Reprinted with permission from Nagel et al. [27]. Copyright (1992) Macmillan Maga-
zines Limited.
Fig. 2. Fast and slow ‘rundown’ of steady-state CFTR current, induced by removal of PKA activation. Insets show change of relaxa-
tion constants concomitant with rundown. Reproduced from Weinreich et al. [43], with copyright permission of the Rockefeller Uni-
versity Press.
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cGK) were also shown to phosphorylate CFTR, and
cGK II is able to activate CFTR which might be
important physiologically in intestine where cGK II
is predominantly expressed [32].
3. Hydrolyzable nucleoside triphosphates are required
to open CFTR
Phosphorylation by PKA is a necessary, however
not su⁄cient, requirement to open CFTR channels.
As shown in Fig. 1, the chloride current decays to
zero upon removal of ATP. The same dependency of
CFTR upon ATP was shown for heterologously ex-
pressed CFTR in di¡erent expression systems [33,34].
By using the speci¢c PKA-inhibitor PKI it could be
shown that the action of ATP is completely inde-
pendent of the ATP-requiring activity of PKA
[27,34].
It was then shown that other nucleoside triphos-
phates could replace ATP, albeit with less potency,
whereas ADP or the non-hydrolyzable ATP-analog
AMP-PNP were unable to open CFTR channels.
This was interpreted as indication that ATP hydrol-
ysis is involved in CFTR gating [27,34]. Further sup-
port for the hypothesis that ATP hydrolysis occurs
during CFTR gating came from the observation that
Mg2 is another necessary cofactor for opening
[34,35] as well as from direct demonstration of ATP-
ase activity of puri¢ed CFTR [36].
The ATP-dependence of CFTR-open probability
shows saturation with K1=2 constants in the range
of 25^300 WM (e.g. [28,33,34]). The rather large var-
iation is probably caused by di¡erences in recording
conditions, like temperature (37‡C or room temper-
ature) and, more importantly, by the di¡erent degree
of phosphorylation of CFTR [37]. CFTR’s activation
by ATP was modeled in analogy to ligand-gated
channels by some groups [33,38], although this com-
pletely ignores the fact (described in detail below)
that ATP hydrolysis and not solely binding and dis-
sociation are governing the gating cycle.
Evidence for irreversible steps in the gating cycle
(as expected for involvement of ATP hydrolysis) was
presented from careful single-channel analysis ob-
serving two open states which were not distributed
randomly [35]. A high activation energy for channel
opening [39] can also be seen as supporting the no-
tion of ATP hydrolysis. A recent study on the gating
of CFTR chloride channels by ATP hydrolysis led to
a quantitative analysis of a cyclic gating scheme [40].
4. The degree of phosphorylation modulates open
probability and kinetic constants
Much information on the regulation of CFTR has
been obtained from single-channel studies, either
with BLM or with membrane patches (for review
see [13,15,41]). CFTR channel gating, i.e. opening
and closing of channels, appears usually slow with
little voltage dependence. In most studies gating
could be described by one or two open-time con-
stants (the slow one in the range of several 100 ms)
and two to three closed-time constants (the slowest
one again in the range of several 100 ms, depending
on [ATP]), probably depending on taking into con-
sideration a short closed-time constant of 2^10 ms.
Most authors agree that the e¡ect of ATP concen-
tration is on the slow closed time constant with in-
creasing [ATP] leading to a decreasing closed time. A
recent study, however, also found a stimulating in-
£uence of ATP on the open time constant [40]. As
even deleting 11 possible phosphorylation sites for
PKA on CFTR still led to PKA-mediated activation
[42] the exact status of phosphorylation might be
very important in determining these constants.
A di¡erent approach to study the kinetics of
CFTR was introduced by pre-steady-state experi-
ments studying the response of many CFTR chan-
nels to fast solution changes [43]. Characteristic re-
laxation time constants could be obtained (see insets
in Fig. 2) when changing the (cytoplasmic) bath sol-
ution to one containing ATP and also upon return-
ing to an ATP-free solution. Fig. 2 shows addition-
ally how the ATP-induced chloride current decreases
with a fast (in the range of 10 s) and a slow (in the
range of hundreds of seconds) time constant after
fast removal of PKA. This ‘rundown’ must be caused
by dephosphorylation of CFTR by membrane-bound
protein phosphatases [28]. The insets show that with
advancing dephosphorylation activation by ATP be-
comes faster. Similarly upon withdrawal of ATP the
inactivation got faster. Unfortunately this modula-
tion of gating by phosphorylation could not yet
quantitatively be analyzed on the single-channel lev-
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el. A reversibly increased open probability, though,
was already described as depending on the presence
of PKA [44]. Recently, it was proposed that the ten
dibasic PKA consensus sites control the bursting rate
(i.e. the inverse of the main closed time) and open
probability of CFTR by increasing the apparent af-
¢nity for ATP [37]. Additional factors must come
into play, however, as in the example of Fig. 2 the
K1=2 for ATP of partially phosphorylated CFTR is
about 80 WM [28,43] and [ATP] is, when applied, 500
WM, i.e. virtually saturating.
5. A non-hydrolyzable ATP-analog binds to CFTR
and inhibits ATP-mediated opening
As soon as the nucleoside triphosphate require-
ment for CFTR opening was recognized the e¡ect
of hydrolysis-resistant ATP-analogs was studied. Ad-
enylylimidodiphosphate (AMP-PNP), an ATP-ana-
log that is structurally very similar to ATP, but re-
sistant to hydrolysis by many ATPases, was unable
to open PKA-phosphorylated CFTR so that ATP
hydrolysis was invoked as requirement for CFTR
opening [27,34]. This was disputed by some on the
grounds that no inhibitory interaction between
AMP-PNP and CFTR in experiments with ATP
and AMP-PNP was observed [45,46]. Such inhibition
of steady-state current or open-probability of single
channels is indeed expected if AMP-PNP-binding to
CFTR is competitive with ATP. But this expected
inhibition is di⁄cult to observe because of the acti-
vating e¡ect of AMP-PNP under certain conditions
(see below). Recently, evidence was obtained for in-
hibitory binding by AMP-PNP from measurements
of the dwell time until channels got locked open by
AMP-PNP [47] and from pre-steady-state experi-
ments with fast solution changes between AMP-
PNP and ATP [43], see Fig. 3.
Fig. 3 shows that AMP-PNP is not able to open
CFTR channels but a subsequent change to ATP
reveals by its slowed response that AMP-PNP must
have bound to CFTR. The much slower activation
by ATP therefore re£ects the slow dissociation of
AMP-PNP from CFTR.
6. The non-hydrolyzable ATP-analog AMP-PNP
reveals the modulating function of a second
nucleotide binding site
Fig. 3 also shows that, when changing from ATP
to AMP-PNP, a substantial portion of CFTR chan-
nels exhibits drastically slowed closing upon removal
of ATP (even after removal of AMP-PNP), when
compared to the control changes from ATP to zero
nucleotide at the beginning and end of the current
recording. Such a stimulating action of the non-hy-
drolyzable ATP-analog AMP-PNP was ¢rst observed
with human CFTR in sweat gland ducts [48]
although it was not recognized at the time that re-
sidual ATP was crucial for the observed stimulating
action of AMP-PNP. The stimulating e¡ect of AMP-
PNP was therefore interpreted as evidence against
involvement of ATP hydrolysis in CFTR channel
opening [48].
The stimulating e¡ect of AMP-PNP could be ex-
plained by binding of AMP-PNP to a second site, as
¢rst suggested by Hwang et al. [44] for cardiac
CFTR. The authors proposed that binding of
AMP-PNP to this site prevents closing until it slowly
dissociates from CFTR. But because this site should
normally be occupied by ATP and because CFTR
channels close much faster upon removal of ATP
in the absence of AMP-PNP (see ¢rst and last ATP
pulse in Fig. 3) it was concluded that ATP also gets
hydrolyzed at this second site [44]. These studies led
to a new model of CFTR regulation by ATP binding
and hydrolysis at two nucleotide binding sites (NBD)
which will be outlined below. The involvement of
Fig. 3. The e¡ect of ATP and AMP-PNP on PKA-phosphory-
lated CFTR. Reproduced from Weinreich et al. [43], with copy-
right permission of the Rockefeller University Press.
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two NBD in the regulation of CFTR was then also
con¢rmed for human epithelial CFTR [49], hetero-
logously expressed and studied in BLM.
Applying a mixture of ATP and AMP-PNP should
therefore result in an increase of the open probability
of CFTR. This was indeed observed with the appear-
ance of channels with greatly prolonged open times,
referred to as ‘locked open’ states [44]. It was also
observed that the probability of channels to become
locked in the open state depends on their degree of
phosphorylation by PKA [44]. The increase of open
probability, and therefore chloride current, by a mix-
ture of ATP and AMP-PNP is demonstrated in Fig.
4 for a membrane patch containing ten thousands of
CFTR channels. It is evident that the stimulating
e¡ect of AMP-PNP is stronger in the beginning of
the experiment, shortly after exposure to PKA, com-
pared to the end when substantial rundown (dephos-
phorylation) has occurred.
In the study by Hwang et al. [44], CFTR conduc-
tance was also measured with the whole-cell patch-
clamp technique whereby intracellular nucleotide
concentrations could be modi¢ed via patch pipette
perfusion. CFTR was studied after selective inhibi-
tion of protein phosphatases (1 and 2a) by okadaic
acid which led to partially phosphorylated CFTR
channels after removing the stimulus for PKA acti-
vation. Whereas the conductance of highly phos-
phorylated CFTR (i.e. during PKA-activation) was
enhanced by a mixture of ATP and AMP-PNP, par-
tially phosphorylated CFTR showed no response to
such a mixture [44]. This behavior is very similar to
the weak e¡ect of AMP-PNP long after PKA-activa-
tion, as shown in Fig. 4.
From these observations a model of CFTR regu-
lation by incremental PKA-mediated phosphoryla-
tion and di¡erential binding of ATP to two function-
ally di¡erent sites was set forth [44], see Fig. 5. The
model can be described by the following restraints:
1. CFTR has to be phosphorylated on at least one
site to yield partially phosphorylated CFTR.
These channels can be recognized by their low
open probability (Po) in single-channel measure-
ments and are called partially phosphorylated
CFTR.
2. ATP binding and hydrolysis at one nucleotide
binding site (which was called NBD-A) leads to
opening (bursts) of partially phosphorylated
CFTR. Channels will close permanently after dis-
sociation of the hydrolysis products.
3. If CFTR is phosphorylated at one or more further
site(s) ATP binds at NBD-A and then another
ATP can bind to a second site (NBD-B) where
it prolongs the openings of CFTR, most probably
by inhibiting release of hydrolysis products at
NBD-A.
4. If AMP-PNP, instead of ATP, binds to NBD-B,
the channels stay open for very long times (they
become ‘locked’ open). Therefore it can be con-
cluded that normally ATP also gets hydrolyzed at
NBD-B because much faster closing is observed
after ATP removal when compared to AMP-
PNP removal.
In summary, this model proposes ATP hydrolysis
at one site (NBD-A) to be required for CFTR open-
ing and optional ATP hydrolysis (or very slow dis-
sociation as in the case of AMP-PNP) at another site
(NBD-B) to precede CFTR closing. Therefore this
model implies no absolute requirement for ATP hy-
drolysis at NBD-B to close CFTR. Speci¢cally, it
hypothesises that partially phosphorylated (low-Po-
CFTR) channels do not allow binding of ATP to
NBD-B which leads to relatively fast dissociation
of hydrolysis products at NBD-A and therefore fast-
er closing of CFTR.
Keeping in mind the primary structure of CFTR
Fig. 4. Phosphorylation-dependent stimulation of CFTR by a
mixture of ATP and AMP-PNP. From Weinreich and Nagel,
unpublished observations.
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with its nucleotide binding folds NBF1 and NBF2
[3], the question emerges which NBF could be
NBD-A or NBD-B. From experiments with mutants
with defective NBF1 or NBF2 [40,49^51], it was con-
cluded that NBD-A most probably is on NBF1 and
NBD-B on NBF2.
It can be assumed that speci¢c phosphorylation
sites on CFTR control the accessibility of NBD-A
and NBD-B which, however, are not yet identi¢ed.
The study by Mathews et al. [37] was a ¢rst step
towards this goal by pointing out the importance,
but not exclusivity of the dibasic PKA-sites in con-
trol of NBD-B. They found that even 8SA-CFTR
(where eight dibasic PKA-consensus-site serines on
the R-domain were replaced by alanines) could be
locked open by AMP-PNP although with longer de-
lay.
Gunderson and Kopito [35] introduced a di¡erent
model for CFTR-regulation at two nucleotide bind-
ing sites. In their model, ATP hydrolysis at NBF1
‘activates’ CFTR, but only binding of ATP to NBF2
opens the CFTR channel. Therefore ATP hydrolysis
(or dissociation in the case of AMP-PNP) at NBF2 is
absolutely required for CFTR to close. Probably
they did not ¢nd the distinction between partially
and highly phosphorylated CFTR because in their
system CFTR was always su⁄ciently phosphorylated
to allow binding of ATP or AMP-PNP to NBF2.
7. The modulating e¡ect of ATP hydrolysis products
and their analogs
It was shown earlier that ADP is not able to open
CFTR chloride channels [27,34]. ADP shows a
strong inhibitory e¡ect on CFTR activity when
used in mixtures with ATP [45,52]. This inhibitory
e¡ect of ADP could be modeled well by competitive
binding of ADP instead of ATP with an apparently
higher a⁄nity for ADP than for ATP [43,45,52].
The modulating e¡ect of ADP was studied further
in pre-steady-state experiments with fast solution
change. Fig. 6 shows the CFTR chloride current in
response to the indicated nucleotides in A and at
higher time resolution in B. Weinreich et al. [43]
found a slowed relaxation constant when changing
from an ADP- to an ATP-containing solution, as
expected for competitive binding of ADP to NBD-
A ( = NBF1), see Fig. 6B, left column: trace b com-
pared to a or c. Rather unexpected and surprising,
however, was the ¢nding that ADP accelerated the
closing of CFTR when changing from an ATP- to an
ADP-containing solution (Fig. 6B, right column:
trace b compared to a or c) [43]. Because this obser-
vation could not be explained by competitive binding
of ADP to NBD-A ( = NBF1) we hypothesized bind-
ing of ADP to another site, either binding to NBD-A
with still bound Pi or binding to NBD-B ( = NBF2).
Fig. 5. Model of phosphorylation-dependent action of ATP at two nucleotide binding sites. For details see main text. From Hwang et
al. [44], with permission. Copyright (1994) National Academy of Sciences, USA.
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In principle, acceleration of CFTR closing by re-
versal of ATP hydrolysis via ADP and CFTR-bound
Pi should be possible if after ATP hydrolysis ADP is
released ¢rst. However, this is unlikely to be the case
for another member of the ABC transporter family,
MDR, where substantial evidence was accumulated
for a mechanism with Pi release preceding ADP re-
lease (for review see [53]). We therefore turned to a
model where ADP-binding to NBF2 accelerates clos-
ing of CFTR, see Section 8 and Fig. 7.
When studying mutants in NBF1 and NBF2, An-
derson and Welsh [52] concluded that the inhibitory
e¡ect of ADP is mediated at NBF2. Mutants in
NBF2 showed no inhibition by ADP. However, the
(to ATP) competitive inhibition of CFTR opening by
ADP would be expected to occur at NBF1. It re-
mains therefore the possibility that ADP-binding to
NBF2 and ATP-binding to NBF1 are antagonistic,
leading to competitive behavior, even if not compet-
ing for binding to the same site. This could be anal-
ogous to the recent ¢nding for SUR1, another ABC
‘transporter’, that MgADP, through binding at
NBF2, antagonises binding of ATP at NBF1 [54].
Certainly more experiments are necessary to decide
this open question.
Inorganic phosphate, the other hydrolysis product,
could be expected to inhibit, similarly to ADP. Sur-
prisingly, this is not the case [55]. Phosphate-stimu-
lated CFTR chloride channels, with an estimated
EC50 of 5 mM, by increasing the open probability.
An e¡ect of phosphate on single-channel conduc-
tance could be excluded. Single-channel analysis con-
cluded that ‘‘the primary e¡ect of Pi was to increase
the rate of channel transition to the burst (open)
state, with negligible e¡ects on the bursts them-
selves’’ [55]. Although most likely the e¡ect of Pi is
mediated via NBF1 or NBF2, at present the site of
action is not clear.
Earlier it was found that the phosphate transition
state analogs ortho-vanadate or beryllium £uoride
also have a strong stimulatory in£uence on CFTR,
Fig. 6. Modulation of relaxation constants by ADP. For details
see main text. Reproduced from Weinreich et al. [43], with
copyright permission of the Rockefeller University Press.
Fig. 7. Model of CFTR regulation by interaction of nucleotides
at two NBD. Reproduced from Weinreich et al. [43], with
copyright permission of the Rockefeller University Press.
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but in contrast to inorganic phosphate, by locking
the channel in the open bursting state [56]. In fact,
mean burst times were increased by two to three
orders of magnitude [49,56]. These e¡ects were inter-
preted as additional evidence for coupling of CFTR
gating to an ATP hydrolysis cycle. As for inorganic
phosphate, it is not clear, from these studies, at
which NBF vanadate and other phosphate analogs
exert their e¡ect. A recent biochemical study with
CFTR containing membrane fragments [57] showed
that ortho-vanadate enhanced nucleotide occlusion
at NBF1 and induced nucleotide occlusion (not
seen without ortho-vanadate) at NBF2. A possible
conclusion, therefore, is that vanadate acts at
NBF1 which would be in agreement with the obser-
vation that the degree of phosphorylation is not cru-
cial for the e¡ect of vanadate [56]. Ma et al. found
[58] that a mutant, lacking most of the R-domain (aa
708^835), shows inhibition by ortho-vanadate. Fur-
ther experiments are needed to clarify vanadate’s site
of action.
A similar drastic increase of open burst time was
also described for pyrophosphate (PPi) [49], again
without knowing the site of action. Carson et al.
[50] speculated that PPi interacts with NBF2 because
mutations of conserved residues in NBF2, but not in
NBF1, signi¢cantly reduced the stimulatory e¡ect of
PPi on CFTR [15]. The above-mentioned mutant,
lacking most of the R-domain, showed inhibition
by PPi whereas CFTR-WT was stimulated by PPi
at concentrations up to 5 mM and increasingly in-
hibited at higher concentrations [58] which could in-
dicate interaction of PPi at two di¡erent sites.
8. A model for CFTR regulation by ATP and ADP
Investigation of CFTR chloride channel gating has
uncovered a complex mechanism for the regulation
of channel opening and closing by protein phosphor-
ylation and interaction with di¡erent nucleotides.
Although it is quite clear that the degree of phos-
phorylation modulates activity, so far there exist
only vague ideas how this is accomplished. From
studies with mutants it became clear that higher
phosphorylation increases the apparent a⁄nity to
ATP [15,37]. But phosphorylation must also increase
the open probability at saturating ATP concentra-
tion as can be deduced from the strong stimulating
e¡ect of PKA, seen in Fig. 2 where [ATP] is very
likely close to saturation [28,43] throughout the
shown time of recording.
Several models for CFTR gating by nucleotides
have been proposed over the last 5 years. These in-
clude models with ATP binding and dissociation,
analogous to ligand-gated channels, e.g. simulating
the ATP- and ADP-dependence of CFTR-open
probability quite well [33,38,45], and models involv-
ing ATP hydrolysis at one or two sites ([15,40,
43,44,50,53]) which explain much better the e¡ects
observed with nucleotide- and hydrolysis product-
analogs.
When analyzing ATP-dependent single-channel
gating of CFTR it is tempting to assume that the
observed channel dwell times correspond (inversely)
to rate constants of the gating cycle. At least two
serious problems make an assignment di⁄cult: (1)
the (unknown) degree of phosphorylation will mod-
ulate the determined constants; and (2) whereas ob-
viously for CFTR gating, more than two intermedi-
ates of CFTR exist, only two (or with a substate
three) states, i.e. an open and a closed state, can be
distinguished in single-channel analysis. Analysis of
dwell times often yields several time constants as this
was also the case for CFTR. But it is not obvious
how to calculate the ‘turnover time’ for CFTR gating
from these constants. In most studies, the sum of
open and closed times amounts to less than 1 s,
whereas pre-steady-state relaxations yield constants
of V1 s and longer (depending on degree of phos-
phorylation) [43]. It also has to be kept in mind that
even for energy-driven cyclic gating schemes, revers-
ible partial reactions are possible and are in fact also
observed for active ion-motive ATPases, like, for ex-
ample, the Na,K-ATPase (for review see [59]). In
the case of CFTR, it is therefore conceivable to ob-
serve reversible openings and closings despite an ir-
reversible gating cycle.
An alternative approach to steady-state measure-
ments of single-channel gating are pre-steady-state
experiments with fast solution changes and measur-
ing the relaxation of many channels to a new steady
state. This approach is widely used for the investiga-
tion of active transport systems with their much
smaller current contribution by a single molecule
(for review see [59]). It showed for CFTR that during
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the lifetime of a typical patch clamp experiment con-
siderable changes of relaxation time constants can be
observed [43]. Generally the rates for activation and
inactivation become faster with continuing dephos-
phorylation. This could be caused by changes in
the availability of NBD-B (i.e. preferring the S3 to
S1 transition at lower phosphorylation, see Fig. 7)
and/or by changes in individual rate constants or
equilibriums.
The model of CFTR regulation by Hwang et al.
[44], shown in Fig. 5, was further developed by Se-
nior and Gadsby [53] and Gadsby and Nairn [13].
Based on functional and sequence similarity to G-
proteins, it was proposed that NBF2 always binds
a nucleotide, either ADP or ATP. Such a model
can accommodate the slowed opening of CFTR
when changing from ADP to ATP, but it cannot
explain the accelerated closing, observed when
changing from ATP to ADP, see Fig. 6. Therefore
we adapted the model to take account of the ob-
served e¡ect of ADP, see Fig. 7 [43].
The model of CFTR regulation by nucleotides,
shown in Fig. 7, is a minimal model consisting of
two closed and three activated states of CFTR.
The activated state was introduced instead of an
(in the literature more popular) open state to de¢ne
a state which could be an open state or a state that
actually embodies an equilibrium between a closed
and an open state (e.g. open burst). This seemed
necessary as long as kinetic constants from steady-
state and pre-steady-state experiments were not care-
fully compared for consistency, even though it is
quite conceivable and might turn out to be true
that the activated state is in fact an open state.
In contrast to previous models [13,15], the closed
states S1 and S2 show no bound nucleotide on NBD-
B (NBF2), basically because no evidence for such
tight ADP-binding in pre-steady-state experiments
was found, whereas the slowed opening in experi-
ments with solution changes from ADP to ATP
(see Fig. 6) hints at [ADP]-dependent binding of
ADP to state S1 (possibly at NBD-A, but see [52]).
The activated state S3 must have an empty NBD-B
site as can be deduced from the accelerated closing in
the presence of ADP. This accelerated closing by
ADP is explained by binding of ADP to NBD-B at
S3 which leads to state S5 and fast closing.
If ATP instead of ADP binds to NBD-B on S3 this
will lead to a prolonged activated state S4 which
requires ATP hydrolysis at NBD-B to reach state
S5. The ADP then bound to NBD-B induces fast
conversion to the closed state S1. Also in this model,
ATP binding to NBD-B (at S3) is limited by the
degree of phosphorylation of CFTR [44]. Whether
ADP binding to NBD-B at S3 is also limited by
the degree of phosphorylation, cannot be answered
for certain as yet. The single relaxation constant ob-
tained when changing from ATP to ADP (see Fig. 6
and [43]) seems to suggest otherwise. Obviously more
experiments are needed to answer such speci¢c ques-
tions.
In summary, this model can explain quite well the
observed interaction of nucleotides with CFTR. But
kinetic constants in this cyclic model are dependent
on the degree of phosphorylation of CFTR (see Fig.
2). To sort out the contribution to this cycle of more
than 11 phosphorylation sites by PKA alone, most of
them activating, some even inhibiting [60], will cer-
tainly take a heroic e¡ort. It can at least be begun by
the choice of mutants which should show less varia-
bility [37].
9. Implications for other ABC transporters?
CFTR is a channel which, once open, passes
enough current to study the activity of a single
CFTR molecule. This feature clearly discerns
CFTR from other ABC transporters, with the excep-
tion of SUR, the regulator of a potassium channel
[61], and makes it attractive as a model for the in-
teraction of ABC transporters with nucleotides.
Although single-channel experiments are powerful,
they often need long recording times and recordings
from many channels to obtain statistically signi¢cant
data. Being steady-state experiments, they still can
miss some information. Studying thousands of
CFTR molecules with a pre-steady-state technique
[43,51,60], more common to the study of active
transporters [59], provided additional information.
As the ABC transporter family is huge, with mem-
bers from microorganisms to mammalians, also the
structural organization of these proteins is quite di-
verse. For example, many microorganisms ‘con-
struct’ an ABC transporter from separate polypepti-
des and often the two nucleotide binding domains
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are built by the same polypeptide. With such an ar-
chitecture, we should not expect to see the same di-
versity in function for the two NBD as we have seen
for CFTR. On the other hand, the ability of both
NBD of CFTR to hydrolyze ATP was conserved in
evolution which might indicate more common design
features than expected from the di¡erent functions of
CFTR and most ABC transporters.
Common principles for ABC transporters prob-
ably exist and a comparison of the three-dimensional
structure of the NBD will be especially interesting,
now that the ¢rst NBD structures from microorgan-
isms are known, see [62], and more are soon to come.
Functional similarities were indeed found for CFTR
and P-glycoprotein (Pgp) [53], but also glaring di¡er-
ences which could be expected considering that they
evolved to di¡erent functions. Mutating the second
NBF in Pgp, for example, completely inhibits its
pumping function [53] whereas the corresponding
mutation leads to prolonged openings of CFTR
channels [35,40,50,51]. Recent biochemical measure-
ments on the above mentioned NBF2 mutant of
CFTR showed that its ATPase activity was inhibited
signi¢cantly, by greater than 50% [63]. Surprisingly
the corresponding NBF1 mutant of CFTR, its ATP-
ase activity again inhibited signi¢cantly, showed no
signi¢cant inhibition of the rate of channel gating.
From these results it was suggested that ATPase ac-
tivity might not be tightly coupled to channel gating
[63]. My personal view would suggest that these ob-
servations reinforce the need for cautious interpreta-
tion of single-channel data. Clearly, more experi-
ments, if possible by using completely di¡erent
approaches, are needed to resolve these exciting
questions.
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